Get the Stockscreener App
2.60
3.70%
-0.10
Imunon Inc stock is traded at $2.60, with a volume of 44,036.
It is down -3.70% in the last 24 hours and down -12.16% over the past month.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
See More
Previous Close:
$2.70
Open:
$2.7
24h Volume:
44,036
Relative Volume:
0.52
Market Cap:
$10.36M
Revenue:
$125.00K
Net Income/Loss:
$-14.50M
P/E Ratio:
-0.5647
EPS:
-4.6043
Net Cash Flow:
$-14.18M
1W Performance:
-4.06%
1M Performance:
-12.16%
6M Performance:
-37.50%
1Y Performance:
-75.08%
1-Day Range:
$2.50
$2.70
1-Week Range:
$2.50
$2.82
52-Week Range:
$2.50
$41.22
Imunon Inc Stock (IMNN) Company Profile
Name
Imunon Inc
Sector
Industry
Phone
(609) 896-9100
Address
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
2.60 | 10.76M | 125.00K | -14.50M | -14.18M | -4.6043 |
VRTX
Vertex Pharmaceuticals Inc
|
453.06 | 113.78B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
719.88 | 75.84B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
802.70 | 50.55B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.48 | 38.99B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
316.55 | 32.69B | 5.76B | 514.49M | 1.10B | 4.4813 |
Imunon Inc Stock (IMNN) Latest News
Imunon (IMNN) Declines -3.00% Amid Market Weakness 2026-05-13Crowd Consensus Signals - newser.com
Imunon | 10-Q: Q1 2026 Earnings Report - Moomoo
Imunon, Inc. (NASDAQ:IMNN) Q1 2026 Earnings Call Transcript - Insider Monkey
Imunon Q1 2026 Earnings Preview - MSN
IMNN: IMUNON Progresses in Clinical Trials with Strong Financial Management - GuruFocus
Imunon’s Earnings Call Balances Survival Gains and Risks - TipRanks
Imunon Inc (IMNN) Q1 2026 Earnings Call Highlights: Promising Clinical Progress Amidst Funding ... By GuruFocus - Investing.com Canada
Imunon Inc (IMNN) Q1 2026 Earnings Call Highlights: Promising Cl - GuruFocus
IMNN's Enrollment in Phase 3 Trial Exceeds Expectations - GuruFocus
IMUNON, INC. Q1 2026 SEC 10-Q Filing: Financial Statements, Risk Factors, and Management Discussion - Minichart
How Should Investors Value Imunon (IMNN) After Q1 2026 Earnings? - GuruFocus
IMUNON Reports Promising Phase 2 Survival Data and Advances Phase 3 OVATION 3 Trial for Ovarian Cancer in Q1 2026 Financial Results Update - Minichart
Earnings call transcript: Imunon Q1 2026 highlights clinical trial progress - Investing.com
IMNN: OVATION 3 enrollment outpaces forecasts as IMNN-001 shows strong survival benefit in ovarian cancer - TradingView
Imunon (IMNN) Q1 2026 Earnings Transcript - AOL.com
Earnings call transcript: Imunon Q1 2026 highlights clinical trial progress By Investing.com - Investing.com Canada
Imunon Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Imunon: FDA Has Reviewed and Is Aligned With Phase 3 Protocol, Confirms Path to BLA Filing - Moomoo
Imunon Releases Q1 2026 Financial Results - AlphaStreet
[10-Q] Imunon, Inc. Quarterly Earnings Report - Stock Titan
Imunon, Inc. 1Q 2026: Net loss $(4.25M), EPS $(0.84) — 10-Q Summary - TradingView
IMUNON ($IMNN) Releases Q1 2026 Earnings - Quiver Quantitative
Imunon Q1 net loss widens as R&D spending rises - TradingView
IMUNON (NASDAQ: IMNN) posts Q1 2026 loss while IMNN-001 shows strong survival data - Stock Titan
Imunon, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Imunon (IMNN.US) is scheduled to release its earnings report before the market opens on May 12. - Moomoo
Number of shareholders of Imunon, Inc. – NASDAQ:IMNN - TradingView
MSN Money - MSN
May 12 webcast to cover IMUNON's Q1 results, Phase 3 ovarian cancer update - Stock Titan
IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026 - Yahoo Finance
Imunon to discuss Q1 2026 financials and Phase 3 trial progress for ovarian cancer immunotherapy on May 12. - Pluang
[ARS] Imunon, Inc. SEC Filing - Stock Titan
Imunon, Inc. Files Form 8-K Announcing Change in Control Severance Agreement – Key Details and Company Information - Minichart
Imunon Adopts Change-of-Control Severance Agreements for Executives - TipRanks
Imunon (NASDAQ: IMNN) approves new change-in-control severance for execs - Stock Titan
Imunon (NASDAQ: IMNN) details 2026 virtual meeting, pay and plan votes - Stock Titan
IMNN Stock Price, Quote & Chart | IMUNON INC (NASDAQ:IMNN) - ChartMill
IMUNON launches up to $9.75M securities offering - MSN
Imunon targets ~80 OVATION 3 patients in the next 12 months as cash runway extends into H2 2026 - MSN
Maxim Group initiates coverage of Imunon (IMNN) with buy recommendation - MSN
IMNN Imunon posts far wider Q4 2025 loss than consensus estimates with zero revenue and unchanged share performance.Trending Buy Opportunities - newser.com
Imunon, Inc. (NASDAQ:IMNN) Q4 2025 Earnings Call Transcript - MSN
Maxim Group Initiates Imunon(IMNN.US) With Buy Rating, Announces Target Price $10 - Moomoo
IMNN Initiated Coverage by Maxim Group -- Rating Set to Buy - GuruFocus
IMNN (Imunon Inc.) shares rise modestly despite posting a far wider than expected fourth quarter 2025 loss.Crowd Entry Points - newser.com
Is Imunon Inc stock a good pick for beginnersWeekly Trade Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Imunon Inc. (IMNN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Imunon (IMNN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Guidance Update: Can Imunon Inc reach all time highs this year2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn
Institution Moves: Can Imunon Inc sustain earnings growth2026 Outlook & AI Forecasted Stock Moves - baoquankhu1.vn
Investment Review: Can Imunon Inc continue delivering strong returns2026 Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Imunon Inc Stock (IMNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
3.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):